Skip to main content

Table 1 Demographic characteristics, body composition, metabolic parameters and medications of 133 morbidly obese patients

From: The relationship between various measures of obesity and arterial stiffness in morbidly obese patients

Variable Total (n = 133) Male (n = 54) Female (n = 79) P-value
Age (years) 43 (11) 45 (11) 41 (10) 0.107
Hypertension* (yes/no) 90 (68%) 44 (81%) 46 (58%) 0.005
Type 2 diabetes (yes/no) 38 (29%) 25 (46%) 13 (17%) <0.001
Ischemic heart disease (yes/no) 7 (5.3%) 6 (11.1%) 1 (1.3%) 0.018
Current smoker (yes/no) 20 (15%) 6 (11%) 14 (18%) 0.340
Weight (kg) 132 (22) 146 (23) 121 (16) <0.001
Various measures of body composition
Waist-to-hip ratio 0.99 (0.10) 1.17 (0.07) 0.94 (0.07) <0.001
Waist-to-height ratio 75.3 (6.4) 79.2 (6.2) 74.4 (5.9) <0.001
Waist circumference (cm) 131 (14) 142 (12) 124 (10) <0.001
BMI (kg/m2) 44.5 (5.6) 46.1 (6.3) 43.5 (4.8) 0.008
Fat mass (kg) 63 (13) 66 (16) 61 (11) 0.055
Fat free mass (kg) 69 (13) 81 (10) 61 (7) <0.001
Visceral fat area (cm2 ) 242 (48) 262 (55) 228 (37) <0.001
Metabolic variables
apoB/apoA-1 ratio 0.7 (0.2) 0.7 (0.2) 0.7 (0.2) 0.550
Fasting insulin (pmol/L) 100 (85) 125 (120) 87 (49) 0.048
HOMA-IR† 4.6 (4.4) 6.1 (6.3) 3.5 (2.0) 0.002
Fasting glucose (mmol/l) 6.0 (2.2) 6.5 (2.7) 5.4 (1.1) 0.002
B-HbA1c (%) 6.2 (1.3) 6.5 (1.6) 5.7 (0.7) 0.001
Pulse pressure (mmHg) 62 (16) 63 (15) 61 (17) 0.471
Medication     
β-blocker (yes/no) 13 (10%) 8 (15%) 5 (6%) 0.134
Calsium-channel blocker (yes/no) 17 (13%) 10 (19%) 7 (9%) 0.125
Inhibitors of the RAA-system (yes/no) 37 (28%) 23 (43%) 14 (18%) 0.003
Statins (yes/no) 18 (14%) 13 (24%) 5 (6%) 0.008
  1. Data are given as number (%) or mean (SD). *Hypertension is defined by the patient receiving antihypertensive medication or having systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg. † Homeostasis Model Assessment Insulin Resistance